Natural products targeting human lactate dehydrogenases for cancer therapy: A mini review

Huankai Yao1, Feng Yang2, Yan Li1

  • 1Department of Microbial and Biochemical Pharmacy, School of Pharmacy, Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou, Jiangsu, China.

Frontiers in Chemistry
|October 17, 2022
PubMed

Insights

Natural products offer potential anticancer agents by inhibiting human lactate dehydrogenase (LDH), a key enzyme in cancer cell metabolism. This review explores diverse natural compounds targeting LDH for future cancer therapy development.

Area of Science:

  • Biochemistry
  • Oncology
  • Pharmacology

Background:

  • Cancer cells exhibit altered metabolism, a hallmark of tumor progression.
  • Human lactate dehydrogenase (LDH) is crucial for aerobic glycolysis in cancer cells, making it a therapeutic target.
  • Natural products are a rich source of novel drug candidates.

Purpose of the Study:

  • To review natural compounds that inhibit human lactate dehydrogenase (LDH).
  • To discuss the potential of natural LDH inhibitors in cancer therapy.
  • To explore future directions in discovering natural LDH inhibitors.

Main Methods:

  • Literature review of natural compounds targeting LDH.
  • Analysis of diverse chemical structures of identified inhibitors.
  • Discussion of therapeutic implications and future research avenues.

Main Results:

  • Several natural compounds with LDH inhibitory activity have been identified.
  • These compounds originate from diverse structural classes.
  • The review synthesizes current knowledge on natural LDH inhibitors.

Conclusions:

  • Natural products represent a promising avenue for developing novel anticancer agents targeting LDH.
  • Further research into natural LDH inhibitors could lead to new cancer therapies.
  • Understanding the structure-activity relationships of these compounds is key for future drug discovery.

Related Concept Videos